Cowen said the risk reward for Endo Pharmaceuticals remains compelling citing the pricing of its generic Lidoderm drug and the lack of appreciation for the ultimate size and durability of its ...

PHILADELPHIA (Legal Newsline) – Endo Health Solutions Inc. and its subsidiary, Endo Pharmaceuticals, have agreed to a $171.9 million settlement with the federal government to resolve off-label ...

On December 12, Endo Pharmaceuticals received FDA approval for a drug called Opana ER. This new iteration of Opana is now crush-resistant, meaning that patients will be safe when administering the ...

Endo Pharmaceuticals’ plan to buy out pelvic care company American Medical Systems for $2.9 billion is another step in Endo’s quest to become more diversified, according to a report by Bloomberg ...

Endo Pharmaceuticals and its flagship drug, Percocet, became widely known, both in the lives of Delaware residents and nationwide. Its creation dates back to the First State’s namesake company ...

Endo Pharmaceuticals (NASDAQ:ENDP - News), a maker of branded and generic drugs, sees 2011 EPS of $4.20-$4.30, below views for $4.40. It expects sales of $2.35 bil-$2.45 bil, below consensus ...

The stock price of Endo Pharmaceuticals has seen a stellar 58% rise over the last month, while it is up 31% in a week. There are a couple of factors that fueled this growth. First, the company ...

RALEIGH, N.C. -- Endo Pharmaceuticals now owes North Carolina $1.5 million. Attorney General Roy Cooper announced Friday it's part of a settlement to resolve allegations of unlawful marketing.

Ruth Mantell SAN FRANCISCO (MarketWatch) -- An Endo Pharmaceuticals Holdings Inc. endp unit on Wednesday said it has received a subpoena from the Department of Health and Human Services, Office of ...

Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XR® in Canada PRESS RELEASE GlobeNewswire Jun. 5, 2017, 02:55 AM ...

Endo Pharmaceuticals Holdings Inc. said Friday that it has recalled two lots of the painkiller Endocet, after some bottles were found to contain tablets that had a higher dosage of acetaminophen ...

NEW YORK (MarketWatch) -- Endo Pharmaceuticals endp was upgraded 2 notches to strong buy from neutral at First Albany due primarily to valuation, given the stock's weakness over the last 2 weeks ...